Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus
Status unconfirmed · Not applicable
Conditions studied: HIV Infections
In brief
Drug resistance may develop in HIV infected patients who take anti-HIV drugs, but most patients do well if they continue taking them. The purpose of this study is to test the effectiveness of a short, intensified course of anti-HIV drugs for controlling HIV infection in adults who have virus resistant to multiple drugs.
Key facts
- Study ID
- NCT00102934
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 20
- Starts
- 2003-03-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2008-09-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- HIV viral load of more than 1000 copies/ml
- On stable antiretroviral therapy
- Have multidrug resistance
You may not qualify if…
- Require immunomodulatory drugs
Where it is running
- San Francisco General Hospital — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.